Overview

Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The study was designed to test whether short-term treatment with a very low-dose combination of fluvastatin and valsartan could induce improvement of endothelial function, arterial stiffness, vascular inflammation, oxidative stress and expression of protective genes in subjects with moderate cardiovascular risk.
Phase:
N/A
Details
Lead Sponsor:
University Medical Centre Ljubljana
Treatments:
Valsartan